rs61543423
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_021098.3(CACNA1H):c.3408C>T(p.Gly1136Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000227 in 1,543,550 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00024 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 1 hom. )
Consequence
CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.476
Publications
1 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 16-1209076-C-T is Benign according to our data. Variant chr16-1209076-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 529690.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.476 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000236 (36/152276) while in subpopulation NFE AF = 0.000397 (27/68008). AF 95% confidence interval is 0.00028. There are 0 homozygotes in GnomAd4. There are 16 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 36 AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.3369C>T | p.Gly1123Gly | synonymous_variant | Exon 17 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.3369C>T | p.Gly1123Gly | synonymous_variant | Exon 17 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.3408C>T | p.Gly1136Gly | synonymous_variant | Exon 17 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*1321C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*2855C>T | non_coding_transcript_exon_variant | Exon 16 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.3408C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000640028.1 | n.*1321C>T | 3_prime_UTR_variant | Exon 17 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*2855C>T | 3_prime_UTR_variant | Exon 16 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152158Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
36
AN:
152158
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000229 AC: 34AN: 148452 AF XY: 0.000266 show subpopulations
GnomAD2 exomes
AF:
AC:
34
AN:
148452
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000226 AC: 314AN: 1391274Hom.: 1 Cov.: 31 AF XY: 0.000220 AC XY: 151AN XY: 686824 show subpopulations
GnomAD4 exome
AF:
AC:
314
AN:
1391274
Hom.:
Cov.:
31
AF XY:
AC XY:
151
AN XY:
686824
show subpopulations
African (AFR)
AF:
AC:
5
AN:
30982
American (AMR)
AF:
AC:
5
AN:
33232
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
24090
East Asian (EAS)
AF:
AC:
1
AN:
36600
South Asian (SAS)
AF:
AC:
6
AN:
77096
European-Finnish (FIN)
AF:
AC:
1
AN:
45090
Middle Eastern (MID)
AF:
AC:
4
AN:
5426
European-Non Finnish (NFE)
AF:
AC:
270
AN:
1081148
Other (OTH)
AF:
AC:
21
AN:
57610
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
17
33
50
66
83
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000236 AC: 36AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
36
AN:
152276
Hom.:
Cov.:
33
AF XY:
AC XY:
16
AN XY:
74448
show subpopulations
African (AFR)
AF:
AC:
2
AN:
41562
American (AMR)
AF:
AC:
4
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
1
AN:
5154
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
27
AN:
68008
Other (OTH)
AF:
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
May 01, 2018
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.